Friday, January 30, 2026

Is the Mono Diet a Quick Fix or a Health Risk? Experts Weigh In

The mono diet trend on YouTube claims weight loss by eating one food daily, but experts warn it's unsustainable and potentially harmful.

Samsung Display Signals Readiness to Supply Foldable OLEDs, MicroLEDs to Apple and Tesla

Samsung Display's CEO Lee Chung discusses next-gen displays for Apple and Tesla, addressing tariffs' impact on the market.

How Apple’s Siri Will Transform with Google’s Gemini AI: A Game-Changer for 2026

Apple aims to enhance Siri with Google's Gemini AI, improving connectivity and user interaction through an upcoming iOS update.

Tag: biopharmaceuticals

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.